The notice shows that after inspection by the Qinghai Provincial Drug Inspection and Testing Institute, a batch of Zhituo Jiebai Pills produced by Tibet Ganlu Tibetan Medicine Co., Ltd. did not meet the regulations. The non-compliant items were differences in properties and weight. .

According to the State Food and Drug Administration, appearance, odor, taste, solubility and physical constants are recorded under the properties, which reflect the quality characteristics of the drug to a certain extent. The weight difference is an indicator reflecting the uniformity of the drug and is one of the important parameters to ensure accurate drug administration.

It is understood that Tibet Ganlu Tibetan Medicine Co., Ltd. was established in 1998 with a registered capital of 200 million yuan. It is a traditional Tibetan medicine production enterprise with a long history. According to its official website, it has won honors such as "National Advanced Quality Management Unit", "National Contract-abiding and Credit-worthy Enterprise", and "China's Famous Trademark".

On the one hand, it is full of honors, but on the other hand, it is full of negativity. Tianyancha shows that from 2018 to 2021, two branches of Tibet Ganlu Tibetan Medicine Co., Ltd. were included in the list of abnormal business operations.

This article comes from China Economic Net